Comment on Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. Vaccines 2024, 12 , 434.
| Autor: | Volkman HR; Pfizer Inc., New York, NY 10001, USA., Nguyen JL; Pfizer Inc., New York, NY 10001, USA., Mustapha MM; Pfizer Inc., New York, NY 10001, USA., Jodar L; Pfizer Inc., New York, NY 10001, USA., McLaughlin JM; Pfizer Inc., New York, NY 10001, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Vaccines [Vaccines (Basel)] 2024 Oct 17; Vol. 12 (10). Date of Electronic Publication: 2024 Oct 17. |
| DOI: | 10.3390/vaccines12101174 |
| Abstrakt: | We noted three key inconsistencies in the Moderna-funded cost-effectiveness analysis by Fust et al [...]. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|